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Effects of genetic variants on the risk of complex diseases estimated from association
studies are typically small. Nonetheless, variants may have important effects in presence
of specific levels of environmental exposures, and when a trait related to the disease
(endophenotype) is either normal or impaired. We propose polytomous and transition
models to represent the relationship between disease, endophenotype, genotype and
environmental exposure in family studies. Model coefficients were estimated using
generalized estimating equations and were used to derive gene-environment interaction
effects and genotype effects at specific levels of exposure. In a simulation study,
estimates of the effect of a genetic variant were substantially higher when both an
endophenotype and an environmental exposure modifying the variant effect were taken
into account, particularly under transition models, compared to the alternative of ignoring
the endophenotype. Illustration of the proposed modeling with the metabolic syndrome,
abdominal obesity, physical activity and polymorphisms in the NOX3 gene in the Quebec
Family Study revealed that the positive association of the A allele of rs1375713 with
the metabolic syndrome at high levels of physical activity was only detectable in
subjects without abdominal obesity, illustrating the importance of taking into account
the abdominal obesity endophenotype in this analysis.
Keywords: abdominal obesity, endophenotype, familial association studies, generalized estimating equations,
metabolic syndrome, physical activity, polytomous logistic model, transition model
Introduction
Genome-wide association studies (GWAS) have been very successful at identifying genetic
associations reproducible across multiple studies and meeting stringent criteria for statistical
significance, but the effect sizes of the variants detected, measured by relative risks or odds
ratios, are generally small (Altshuler et al., 2008). For genetic variants whose effect is modified
by the environment, the effect estimated by GWAS is a marginal effect, i.e., an average of
large effects in subjects with particular genotype-environment configurations and negligible
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effects in others. Estimating effects at specific levels of a
key environmental exposure is crucial for lifestyle counseling
taking into account genetic information. For instance, the
knowledge that a genetic variant has an important protective
effect against cardio-vascular disease only in the presence of a
sufficient level of physical activity may be a further incentive
to exercise regularly. Most studies of the modifying effects of
environmental exposures have adopted crude stratifications of
exposure to estimate genetic effects, but modeling genetic effects
as a function of a quantitative exposure is likely to be more
informative.
With complex traits, an affected/unaffected status constitutes
a crude phenotypic dichotomy. Increasingly, multiple phenotypic
measurements are used to decompose complex traits into
components with a simpler etiology, which have been called
endophenotypes (Gottesman and Gould, 2003; Szatmari et al.,
2007). In some cases, syndromes are defined on the basis
of impairments on multiple endophenotypes, such as the
metabolic syndrome (MetS), which is defined from diabetes and
cardiovascular risk factors (see Methods). The co-segregation of
a disease and impairment in an endophenotype aggregating in
families suggests genetic variants influencing both traits. This
is one of the reasons why the present study takes advantage of
familial association studies.
Endophenotypes are often used as univariate or multivariate
phenotypes in genetic association studies, in place of the
disease diagnosis. Since the ultimate goal is usually to estimate
the effect of genetic variants on the risk of disease, it is
of interest to jointly analyze the disease with one of its
endophenotypes, and thus hopefully distinguish genetically
distinct sub-types of an heterogeneous disease. In that case, a
genetic variant may have a large effect on disease risk only
when an endophenotype impairment is present or absent, in
addition to require some level of an environmental exposure.
We have previously developed within-family score tests under
polytomous models, which can be used to jointly analyze
the association between polytomous phenotypes defined from
disease status and a dichotomous endophenotype, and two
genetic polymorphisms in family samples (Bureau et al.,
2014). While these tests designed to evaluate gene-gene
interactions are applicable to a gene-environment setting with
a dichotomous exposure, they do not provide effect size
estimates.
In the present paper, we propose statistical modeling
approaches to estimate genetic effects on the risk of disease taking
into account an environmental exposure and a dichotomous
endophenotype. Our goal is to compare genetic effect estimates
and the power to detect them when jointly modeling disease
and endophenotype as a function of exposure vs. ignoring
the endophenotype in the analysis. This comparison is
performed on genetic and environmental data simulated
across a number of scenarios focused on MetS, abdominal
obesity and physical activity in the Quebec Family Study
(QFS), as well as actual genotype data from single nucleotide
polymorphisms (SNPs) detected by GWAS of metabolic
traits and phenotypic and physical activity data from the
QFS.
Methods
Joint Disease-endophenotype Models
We considered two types of disease-endophenotype models:
transition models and polytomous models.
Transition Models
The endophenotype Y1 is supposed to precede the disease
endpoint Y2. The probability of an impairment on the
endophenotype Y1 = 1 is a function of predictor variables:
genotype coded as allele count X, environmental exposure E and
covariates Z. The probability of disease Y2 = 1 is a function of
the endophenotype Y1 and predictor variables. We consider a
logistic model for these two probabilities for comparability with
the polytomous model, but note that other types of binomial
models could be used, such as a log-binomial model. With a
single covariate Z, the transition models can be written:
log
(
P [Y1 = 1|E,X,Z]
P [Y1 = 0|E,X,Z]
)
= α0 + α1E+ α2X
+α3EX + α4Z (1)
log
(
P [Y2 = 1|Y1,E,X,Z]
P [Y2 = 0|Y1,E,X,Z]
)
= γ0 + γ1E+ γ2X + γ3EX
+γ4Y1 + γ5Y1E+ γ6Y1X
+γ7Y1EX + γ8Z (2)
The model for Y2 in Equation (2) is of interest in the context
of examining the risk of disease. For the stratum without
endophenotype impairment (Y1 = 0), the gene-environment
interaction effect is γ3 and the genotype effect at exposure level
E = e is γ2 + γ3e. Likewise, for the stratum with endophenotype
impairment (Y1 = 1), the gene-environment interaction effect
is γ3 + γ7 and the genotype effect at exposure level E = e is
γ2 + γ6 + (γ3 + γ7)e. All these effects are interpretable as the
log of odds ratios (ORs).
Polytomous Models
In this type of model, the odds of each combination of Y1 and Y2
against a reference category (taken to be Y1 = 0, Y2 = 0) are
modeled separately as functions of predictor variables with each
their own coefficients. Taking the log gives the following logistic
functions:
log
(
P [Y1 = 1,Y2 = 0|E,X,Z]
P [Y1 = 0,Y2 = 0|E,X,Z]
)
= β10 + β11E+ β12X
+β13EX + β14Z (3)
log
(
P [Y1 = 0,Y2 = 1|E,X,Z]
P [Y1 = 0,Y2 = 0|E,X,Z]
)
= β20 + β21E+ β22X
+β23EX + β24Z (4)
log
(
P [Y1 = 1,Y2 = 1|E,X,Z]
P [Y1 = 0,Y2 = 0|E,X,Z]
)
= β30 + β31E+ β32X
+β33EX + β34Z (5)
If one were interested only in genetic and environmental effects
on disease with and without endophenotype impairment, one
could exclude subjects with endophenotype impairment but
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without disease (Y1 = 1, Y2 = 0), and define a trichotomous
model using only Equations (4) and (5). Gene-environment
interaction effects and genotype effects are defined for each of
these phenotype category comparisons in a similar fashion. For
Equation (5) comparing affected subjects with endophenotype
impairment to unaffected subjects without endophenotype
impairment, the interaction effect is β33 and the genotype effect
at exposure level E = e is β32 + β33e. Again, these effects are
interpretable as log-ORs.
These disease-endophenotype models were compared
to a standard disease-only logistic model ignoring the
endophenotype:
log
(
P [Y2 = 1|E,X,Z]
P [Y2 = 0|E,X,Z]
)
= η0+η1E+η2X+η3EX+η4Z (6)
Estimation
We opted for a population level estimation approach, using
generalized estimating equations (GEEs) and empirical estimates
of the variance of coefficient estimates (Zeger et al., 1988) to
deal with dependence between genotype, exposure and outcome
among related subjects. For transition models, we tried two
types of working correlation structures: independence and
relationship specific, i.e., with a distinct correlation estimated
for each of the following relationship pairs: spouses, parent-
offspring, siblings, avuncular, grandparent-grandchild and first
cousins. The estimation was performed using the function geese
from the R package geepack. For polytomous models, only the
independence correlation structure was used. The estimation was
performed using the function nomLORgee from the R package
multgee. The empirical estimator of the variance-covariance
matrix of the coefficient estimates, robust to misspecification of
the correlation structure, was used in all cases.
Testing Strategy
We performed various kinds of Wald tests of model coefficients
to assess the power to detect genotype and gene-environment
interaction effects, where the genotype is coded as an allele count
(allelic effect). Under transition models, tests under the disease
model of Equation (2) were performed separately in subject
with (Y1 = 1) and without (Y1 = 0) an impairment of the
endophenotype, and a Bonferroni correction for performing two
tests of each kind was applied. Under polytomous models, tests
were performed for each of the logistic functions in Equations
(3)–(5), and a Bonferroni correction for performing three tests of
each kind was applied. Under the standard disease-only logistic
model (6), there is only one equation, so only one test of each
kind was performed with no Bonferroni correction. The testing
strategy also depended on the nature of the exposure variable as
outlined below.
Dichotomous Exposure
We performed both a test of the interaction effect itself (e.g., a test
of γ3 + γ7 in Equation (2) for the stratum with endophenotype
impairment Y1 = 1), and a conditional test of the genotype
effect given the exposure, which is the joint 2◦ of freedom test
of the genotype effect in unexposed subjects and the interaction
effect (Kraft et al., 2007). In the stratum with endophenotype
impairment Y1 = 1, for instance, this is the joint test of γ2 + γ6
and γ3 + γ7. Within-family score tests for two locus models
(Bureau et al., 2014) are readily transposable to one locus and a
dichotomous exposure and performed in addition to Wald tests.
Continuous Exposure
With a continuous exposure, it is not possible to perform the
conditional test of the genotype effect given the exposure: the
main effect coefficients of the genotype represent the genotype
effect at an exposure value of 0, which may not be the most
relevant exposure level to observe the effect of gene-exposure
interaction. We adapted the conditional test to the continuous
case by testing association at two representative levels of the
exposure and correcting the significance level for performing two
tests. We opted to estimate and test the genotype effect at the first
and third quartiles of exposure as low and high levels.
Study of Metabolic Syndrome (MetS) and
Physical Activity Motivating the Models
Since the conception of our simulation scenarios was guided by
the application to a GxE analysis of the MetS and abdominal
obesity in relation with physical activity level in the QFS, we
briefly review the characteristics of this syndrome, physical
activity and the QFS before describing our simulation scenarios.
The Quebec Family Study
The QFS cohort includes a total of 951 subjects from 223 families
recruited in the Quebec City area, of which 754 (336 men, 418
women) had genotypes and measurements available on at least
four traits entering the definition of MetS and on the physical
activity score. All phenotypes related to the MetS were measured
in QFS subjects as explained in previous reports (Bossé et al.,
2007; Plourde et al., 2013). Briefly, body weight, height and waist
circumference were measured following standardized procedures
(Lohman et al., 1988). Blood samples were obtained after a 12-
h overnight fast and cholesterol and triglyceride concentrations
were determined enzymatically, while HDL-cholesterol was
determined after precipitation of low-density lipoproteins, as
previously described (Pérusse et al., 1989a). Plasma glucose
was assessed enzymatically and insulin levels were measured
by radioimmunoassay, as previously described (Rice et al.,
1996). Systolic and diastolic blood pressure measurements were
obtained according to the recommendations of the American
Heart Association, as described previously (Pérusse et al., 1989b).
All procedures were approved by the institutional review board of
theMedical Ethics Committee of Laval University and all subjects
gave their informed written consent to participate in the study.
Metabolic Syndrome (MetS)
The MetS is a cluster of risk factors that are associated with
a five-fold increase in the risk of type-2 diabetes and a two-
fold increased risk of cardiovascular disease (Lanktree et al.,
2013; Kaur, 2014; O’Neill and O’Driscoll, 2015). We consider
it as our disease endpoint although it is usually considered
as a precursor to full blown metabolic diseases. According to
the National Cholesterol Education Program - Adult Treatment
Panel III (2002), at least three of the following risk factors
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need to be present to be classified as having MetS: abdominal
obesity (waist circumference ≥ 102 cm for men and ≥ 88 cm for
women), elevated blood pressure (≥130/85mm Hg), moderate
hypertriglyceridemia (plasma triglyceride levels ≥1.7mmol/l),
reduced high-density lipoprotein cholesterol (HDL-C) levels
(<1.0mmol/l men and <1.3mmol/l for women) and fasting
hyperglycemia (≥ 6.1mmol/l). Growing evidence (Després and
Lemieux, 2006; Kloting and Bluher, 2014; Mathieu et al.,
2014; O’Neill and O’Driscoll, 2015) suggests that excess
body fat (particularly abdominal, which is associated with a
proinflammatory state and insulin resistance) is a key component
of the syndrome. Obesity, particularly abdominal obesity, which
is often assessed by measuring waist circumference, is one of
the most prevalent manifestations of MetS. Some causes of MetS
without abdominal obesity are likely to differ from those of
MetS with abdominal obesity, hence the interest in including
abdominal obesity (present or absent) as an endophenotype
when modeling MetS. The prevalence of MetS and abdominal
obesity is well known to increase with age (Ervin, 2009; Janssen
et al., 2011; Riediger and Clara, 2011), a relationship we also
observed in the QFS (see regression coefficient estimates in the
Supplementary Material). In QFS, the prevalence of MetS based
on the above definition reached similar levels in men (23.3%) and
women (21.5%), which is in line with the 2009–2011 Canadian
Health Measures Survey which indicated that 22% of Canadians
aged 18–79 years have MetS (24% in men and 20% in women).
Results from twin and family studies reviewed elsewhere (Teran-
Garcia and Bouchard, 2007; Lanktree et al., 2013; Stancakova and
Laakso, 2014; O’Neill and O’Driscoll, 2015) indicate that both
MetS and its defining risk factors, including abdominal obesity,
are characterized by heritable components.
Physical Activity
Low physical activity level is associated with increased prevalence
of obesity and MetS, and we will use physical activity level
to illustrate how an environmental exposure can modify the
association of genetic variants with MetS. For the purpose of
this study, we use a physical activity score derived from a 3-
day activity record, as described elsewhere (Bouchard et al.,
1983; Pérusse et al., 1989c). Briefly, using the activity record,
subjects were asked to report the dominant activity for each
15min period during 24 h by using a list of activities. Activities
were grouped into 9 different categories (scores 1–9) based on
the energy expenditure associated with each activity, a score
of 1 representing a very low energy expenditure (sleeping or
resting in bed) and a score of 9 representing high-intensity
level physical activity. In the present study we used the sum of
categories 5–9, i.e., the sum, over the 3 days, of 15-min periods
coded as 5–9, as an indicator of moderate to vigorous physical
activity. We previously showed evidence of familial aggregation
for physical activity level measured by this score (Simonen et al.,
2002). Evidence of familial co-aggregation has also been reported
between features of MetS and physical activity (Butte et al.,
2006; Vattikuti et al., 2012). The logit of the prevalence of MetS
and the logit of the prevalence of abdominal obesity exhibit an
overall decreasing relationship with the physical activity score
(Supplementary Figures 1, 2), so we modeled the score linearly
on the logistic scale.
Simulation Scenarios
We conducted a simulation study with the goals of confirming
that the parameter estimates proposed above and associated
standard errors and Wald test statistics have the expected
statistical behavior. Simulation scenarios were inspired from
data on MetS and abdominal obesity available in the QFS
and our previous work (Bureau et al., 2014). A detailed
description of the simulation scenarios can be found in the
Supplementary Material. The following characteristics were
taken into account:
• The prevalence of abdominal obesity and the prevalence of
MetS with and without abdominal obesity (Table 1).
• The association between these prevalences and age.
• For scenarios with a continuous exposure, the relationship of
the physical activity score with age.
• The familial correlation for MetS, abdominal obesity and the
environmental exposure.
• The correlation between MetS, abdominal obesity and the
environmental exposure.
Data were simulated under three joint models of MetS,
abdominal obesity and physical activity:
• Transition model 1: where the interaction between the
environmental exposure and a genetic polymorphism occurs
only in subjects with abdominal obesity (Y1 = 1). For the
scenario with a dichotomous exposure, obese subjects with the
TABLE 1 | Prevalence of metabolic syndrome and its component risk
factors per abdominal obesity status among genotyped subjects from the
Quebec Family Study.
Prevalence Abdominal obesity
N % Affected Non-affected
220 (29.2%) 534 (70.8%)
MetS
Affected 150 19.9 133 (60.5%) 17 (3.2%)
Non-affected 604 80.1 87 517
ELEVATED BLOOD PRESSUREa
Affected 186 24.7 98 (44.5%) 88 (16.5%)
Non-affected 567 75.3 122 445
HYPERTRIGLYCERIDEMIA
Affected 214 28.4 113 (51.4%) 101 (18.9%)
Non-affected 540 71.6 107 433
REDUCED HDL-CHOLESTEROL
Affected 332 44.0 149 (67.7%) 183 (34.3%)
Non-affected 422 56.0 71 351
HYPERGLYCEMIAb
Affected 55 7.4 40 (18.3%) 15 (2.9%)
Non-affected 686 92.6 179 507
aData available for 533 subjects among the 534 non-affected of Abdominal obesity.
bData available for 219 subjects among the 220 affected of Abdominal obesity and 522
subjects among the 534 non-affected of Abdominal obesity.
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exposure form the group susceptible to a genetic effect on the
risk of MetS (susceptible group).
• Transition model 2: where the interaction between the
environmental exposure and a genetic polymorphism occurs
only in subjects without abdominal obesity (Y1 = 0). For the
scenario with a dichotomous exposure, non-obese subjects
with the exposure form the susceptible group.
• A polytomous model where the gene-environment interaction
is such that the genotype influences the onset of MetS (Y2 =
1) only among subjects with abdominal obesity (Y1 = 1), and
where this influence depends on the level of exposure. For the
scenario with a dichotomous exposure, obese subjects with the
exposure form the susceptible group.
For all three scenarios, the exposure could either be a
dichotomous variable with overall prevalence of 50% (e.g., a
score dichotomized at the median) or a quantitative variable
with distribution similar to the QFS physical activity score.
The polytomous model with a dichotomous exposure is the
simulationmodel used by Bureau et al. (2014) where the exposure
is positively associated with Y1 and Y2, contrary to what was
specified in transition models.
The genotype, dichotomous exposure or physical activity
score, abdominal obesity and MetS variables were simulated in
samples with the same size, family structures and age distribution
as the QFS. Each simulated dataset was analyzed with the
transition model, the polytomous model and a dichotomous
model of Y2 (MetS) ignoring Y1 (abdominal obesity). Each
dataset was therefore analyzed with a correctly specified model
and two misspecified models. All simulations were repeated 1000
times.
Results
Simulation Results
Analysis of a genetic variant independent from the risk variant
revealed that the Wald tests involving transition model terms
had approximately correct Type I error rates, except the tests in
subjects without endophenotype impairment for the continuous
exposure, which were noticeably liberal (Supplementary Table 1).
We also noticed slightly higher Type I errors on datasets
simulated from the polytomousmodel than on datasets simulated
from transition models.
Dichotomous Exposure
Table 2 shows the results of the simulation with a dichotomous
exposure for the independence working correlation structure.
Results for the relationship specific correlation structure were
similar (not shown). With correctly specified models (e.g.,
data simulation and analysis under a transition model), the
mean estimated genotype effects in the susceptible group are
similar to the mean interaction effects, as expected since the
genotype effect and interaction effect were identical under
the simulation models (there was no genotype effect in the
unexposed subjects, see Supplementary Material). The mean
SEs of the interaction effect estimates are however much larger
than the mean SEs of the genotype effect estimates, since
TABLE 2 | Simulation results with a dichotomous exposure.
Analysis Genotype effect Interaction effect
model
Effect Mean Mean Estimate Power a,b Power within Effect Mean Mean Estimate Powerb Power within
simulated estimate SE empirical conditional family score simulated estimate SE empirical Wald family score
SD Wald SD
DATA SIMULATED UNDER TRANSITION MODEL 1c
Transitiond 0.693 0.589 0.242 0.248 0.466 – 0.693 0.597 0.423 0.426 0.20 –
Polytomouse – 0.413 0.190 0.199 0.335 0.236 – 0.266 0.336 0.340 0.06 0.118
Disease-onlyf – 0.365 0.166 0.171 0.501 0.303 – 0.309 0.270 0.275 0.22 0.192
DATA SIMULATED UNDER TRANSITION MODEL 2c
Transitiong 0.693 0.607 0.263 0.275 0.420 – 0.693 0.626 0.413 0.427 0.22 –
Polytomoush – 0.592 0.257 0.266 0.375 0.123 – 0.611 0.409 0.420 0.18 0.063
Disease-onlyf – 0.285 0.167 0.169 0.319 0.190 – 0.228 0.270 0.275 0.12 0.128
DATA SIMULATED UNDER POLYTOMOUS MODELc
Transitiond – 1.480 0.294 0.286 0.999 – – 1.48 0.479 0.478 0.80 –
Polytomouse 1.39 0.989 0.195 0.199 0.994 0.943 1.39 0.994 0.334 0.343 0.73 0.895
Disease-onlyf – 0.860 0.170 0.173 1.000 0.934 – 0.864 0.269 0.272 0.90 0.922
aJoint 2 d.f. test of the effect of the genotype in unexposed subjects and of the genotype-environment interaction effect.
bSignificance level set to α = 0.05/2 = 0.025 for transition model, α = 0.05/3 = 0.0167 for polytomous model and α = 0.05 for disease-only model.
cSee Section Dichotomous Exposure of the Supplementary Material.
dThe estimated genotype log-odds ratio is γ2 + γ6 + γ3 + γ7 and the estimated interaction log-odds ratio is γ3 + γ7 from Equation (2).
eThe estimated genotype log-odds ratio is β32 + β33 and the estimated interaction log-odds ratio is β33 from Equation (5).
fThe estimated genotype log-odds ratio is η2 + η3 and the estimated interaction log-odds ratio is η3 from Equation (6).
gThe estimated genotype log-odds ratio is γ2 + γ3 and the estimated interaction log-odds ratio is γ3 from Equation (2).
hThe estimated genotype log-odds ratio is β22 + β23 and the estimated interaction log-odds ratio is β23 from Equation (4).
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interaction effect estimates represent a difference of genotype
effect estimates between the exposed and unexposed groups,
which is more variable than the estimated effect of the genotype
in each of these two groups. As a result, the precision to
estimate and the power to detect the genotype effect is greater
than the precision to estimate and the power to detect the
interaction effect. The power difference occurs both with the
Wald test and the within-family score test. The population-
level Wald test had generally greater power than the within-
family score test, except for detecting interaction effects under
some of the data generation—analysis model combinations
(e.g., with data generated under the polytomous model, the
within-family score test was more powerful in analyses using
the polytomous and disease only model). Confidence interval
coverage of the genotype and interaction effects under correctly
specified models were close to nominal level (Supplementary
Table 2).
We note that the coefficient estimates were attenuated
compared to the coefficient values specified in the simulation
scenarios, as expected given they are population-averaged
estimates, while the specified values are subject-specific (see
Fitzmaurice et al., 2011, chapter 14 on the distinction
between population averaged and subject-specific logistic model
coefficients).
We also observed that the mean estimated genotype and
interaction effects in the standard disease-only model ignoring
the endophenotype Y1 are smaller than the corresponding effects
under joint modeling of Y1 and Y2. For instance, when the
data are simulated from transition model 2, the mean estimated
log-OR for the genotype effect in the exposed subjects is 0.285
under the standard disease model, compared to 0.607 under
the correct transition model and 0.592 under the polytomous
model (category Y1 = 0, Y2 = 1). The interaction effect
under the standard disease model is reduced to a greater extent
than the genotype effect (0.228 compared to 0.626 under the
correct transitionmodel and 0.611 under the polytomousmodel).
The transition model gives higher estimated effects than the
polytomous model, even when the true underlying model is
a polytomous model. The larger effect sizes under the joint
models led to greater power to detect the genetic effect under
transition model 2 (0.42 for the transition model vs. 0.32 for the
disease only model), but not under transition model 1 (0.47 vs.
0.50). The polytomous model, which was taken from a previous
study (Bureau et al., 2014), does not allow us to distinguish
the power of the different approaches to detect the genotype
effect, since the power is close to 1. To detect the interaction
effect, the disease-only and transition models achieve higher
power than the polytomous model, even though the data were
generated under the latter. Power would have been slightly higher
if we had tested the genotype and interaction effects using only
Equations (4) and (5) and dividing the α level by 2 instead of 3
(ignoring subjects with endophenotype impairment but without
disease).
Continuous Exposure
In our simulation scenarios, the variance of the simulated
exposure corresponded to 0.6 times the variance of the physical
activity score, and the first and third quartiles were 140 and
280 respectively. The effect of the minor allele was important
at high exposure levels; it was protective under the transition
models 1 and 2 (Figure 1), and deleterious under the polytomous
model. We report the estimated genotype effects and the power
at the third quartile along with the interaction effects for a
change in exposure level equal to the exposure interquartile
range (140 points) in Table 3. The genotype effects at the first
quartile were low and power to detect them was small (not
shown). The power advantage for the genotype effect test over
the interaction test is even greater than in the dichotomous
case, despite the Bonferroni correction for testing the genotype
effects at two exposure levels. We note that the SE of the
interaction coefficient under the transition and polytomous
models underestimated the empirical SD on data simulated from
transition models 1 and 2. However, no substantial inflation
of the Type I error was detected (Supplementary Table 1).
The mean SE was close to the empirical SD for the genotype
effects for all simulation scenarios and for the interaction
coefficients on data simulated from the polytomous model. As
we observed with the dichotomous exposure, confidence interval
coverage of the genotype and interaction effects under correctly
specified models were close to nominal level (Supplementary
Table 2).
As in the dichotomous case, the mean estimated genotype
and interaction effects in the standard disease-only model for
Y2ignoring the endophenotype Y1 are smaller in absolute value
than the corresponding effects under correct joint modeling of
Y1 and Y2, and even under a misspecified joint model. For
instance, when the data are simulated from transition model
2, the mean estimated log-OR for the genotype effect at an
exposure level of 280 is −0.203 under the standard disease
model compared to −0.950 under the correct transition model
and −0.932 under the polytomous model (category Y1 = 0,
Y2 = 1). The interaction effect is also reduced (−0.092 under the
standard disease model, compared to −0.411 under the correct
transition model and −0.423 under the polytomous model).
Greater effect sizes led to greater power to detect the genotype
effect with data generated from the transition models 1 and 2.
For data generated from the polytomous model, the power to
detect the genotype effect was near 1 for all methods applied,
but we observed that the power to detect the interaction effect
was greatest using the disease-only model. Again, defining the
polytomous model using only Equations (4) and (5) would have
slightly increased power under that model due to the larger α
level.
When the data were simulated from transition model 1 and
analyzed using the polytomous model, we note that the genotype
and interaction effects on the endophenotype impairment among
subjects without the disease (category Y1 = 1, Y2 = 0 vs.
Y1 = 0, Y2 = 0) were detected with the greatest power, and
these are the positive effects reported in Table 3. If a model
without that category were used instead, the effects on the risk
of both disease and endophenotype would be detected with the
greatest power (power = 0.11 for the genotype effect and 0.07
for the interaction effect when applying the same α level as in
Table 3).
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FIGURE 1 | Simulated odds of disease as a function of a genotype X and a continuous exposure E at age 40 under transition model 1. X: number of
minor alleles. Y1 = 1 if an endophenotype impairment is present, 0 otherwise. Dashed vertical lines show the first and third quartiles of E.
Illustration with Physical Activity, Abdominal
Obesity and Metabolic Syndrome in the Quebec
Family Study
We illustrate the impact of jointly considering a disease (MetS)
and an endophenotype (abdominal obesity) on the effect size and
statistical significance of a genetic association at different levels of
an environmental exposure using the QFS physical activity score
as an example. Principal component analysis of the genotypes of
485,023 autosomal SNPs from the 610-Quad Illumina genotyping
array on the QFS and HapMap samples using Eigensoft (Price
et al., 2006) revealed no evidence of population stratification,
the QFS subjects forming a tight cluster near the CEU HapMap
sample. Concordingly, the variance inflation factor for the
comparison of MetS affected and unaffected pedigree founders
was estimated to be 1.000. We therefore decided not to perform
any correction for population stratification.
We selected the gene NOX3 for this illustration because the
SNP rs9322557 was the most significantly associated to waist
circumference in a genome-wide analysis (β = 0.27 cm/allele,
p = 3.2 × 10−7) and this SNP and other showed evidence
of association with various risk factors defining the MetS in
the QFS. NOX3 is part of the Nox family of NADPH oxidases,
involved in generation of reactive-oxygen species (Leto et al.,
2009) and in the development and progression of cardiovascular
disease. The proposed joint modeling was applied to three NOX3
SNPs: rs9322557, rs1375713, and rs12190809. We focus here
on rs1375713 to illustrate the gain achieved with the proposed
joint modeling. The SNP rs12190809 is strongly correlated to
rs1375713 (r2 = 0.72) and gave similar results, while rs9322557
is weakly correlated to the other two (r2 = 0.07) and showed
no evidence of interaction with physical activity level (not
shown). Under a transition model, the interaction effect on MetS
between the A allele of rs1375713 and physical activity level for a
difference in physical activity score of 230 units (the interquartile
range) was strong in subjects without abdominal obesity (OR
[95% confidence interval (CI)] = 3.8 [1.4–10.0], p = 0.014)
but absent among subjects with abdominal obesity (OR [95%
CI] = 0.7 [0.4, 1.2], p = 0.4). Under a polytomous model, where
the adjustment on age differs, the interaction effect on MetS in
subjects without abdominal obesity was even stronger (OR [95%
CI] = 4.1 [1.6, 10.4]). Without stratifying on abdominal obesity,
no interaction effect with respect to MetS was detected (OR [95%
CI] = 1.2 [0.7, 1.8], p = 0.5). Table 4 and Figure 2 help in
interpreting this result. At low levels of moderate to strenuous
physical activity, there is no difference in MetS prevalence as
a function of the rs1375713 genotype, either in the subjects
with or without abdominal obesity. Prevalence of MetS decreases
with increasing levels of moderate to strenuous physical activity
in subjects without abdominal obesity, but the decrease is
accentuated in subjects not carrying the A allele (rs1375713 GG
genotype), making this group susceptible to benefit most from
moderate to strenuous physical activity. The rs1375713 A allele is
hence attenuating the effect of physical activity on the prevalence
of MetS in subjects without abdominal obesity, and can therefore
Frontiers in Genetics | www.frontiersin.org 7 July 2015 | Volume 6 | Article 248
Bureau et al. Disease-endophenotype models with gene-environment interaction
TABLE 3 | Simulation results with a continuous exposure.
Analysis Genotype effect at 3rd Interaction effect (for a 140 points
model quartile of exposure (280) change in exposure level)
Effect Mean Mean Estimate Powera Effect Mean Mean Estimate Powerb
simulated estimate SE empirical SD Wald simulated estimate SE empirical SD Wald
DATA SIMULATED UNDER TRANSITION MODEL 1c
Transitiond −0.973 −0.894 0.240 0.251 0.901 −0.487 −0.446 0.268 0.316 0.220
Polytomouse – 0.518 0.170 0.171 0.668 – 0.189 0.199 0.203 0.074
Disease-onlyf – −0.347 0.155 0.162 0.484 – −0.201 0.187 0.199 0.203
DATA SIMULATED UNDER TRANSITION MODEL 2c
Transitiong −0.973 −0.950 0.300 0.311 0.772 −0.487 −0.423 0.290 0.346 0.208
Polytomoush – −0.932 0.297 0.308 0.720 – −0.411 0.332 0.347 0.159
Disease-onlyf – −0.203 0.154 0.154 0.175 – −0.092 0.188 0.189 0.081
DATA SIMULATED UNDER POLYTOMOUS MODELc
Transitiond – 1.420 0.259 0.264 1.000 – 0.722 0.345 0.350 0.457
Polytomousi 1.433 0.950 0.178 0.179 0.997 0.647 0.443 0.240 0.244 0.282
Disease-onlyf – 0.832 0.154 0.155 0.999 – 0.495 0.202 0.202 0.697
aSignificance level set to α = 0.05/4 = 0.0125 for transition model, α = 0.05/6 = 0.0083 for polytomous model and α = 0.05/2 = 0.025 for disease-only model.
bSignificance level set to α = 0.05/2 = 0.025 for transition model, α = 0.05/3 = 0.0167 for polytomous model and α = 0.05 for disease-only model.
cSee Section Continuous Exposure of the Supplementary Material. Note that the log-odds ratios in the Supplementary Material are reported for a 100 points change in exposure level.
dThe estimated genotype log-odds ratio is γ2 + γ6 + 280(γ3 + γ7 ) and the estimated interaction effect is 140(γ3 + γ7 ) from Equation (2).
eThe estimated genotype log-odds ratio is β12 + 280β13 and the estimated interaction log-odds ratio is 140β13 from Equation (3).
fThe estimated genotype log-odds ratio is η2 + 280η3 and the estimated interaction log-odds ratio is 140η3 from Equation (6).
gThe estimated genotype log-odds ratio is γ2 + 280γ 3 and the estimated interaction log-odds ratio is 140γ3 from Equation (2).
hThe estimated genotype log-odds ratio is β22 + 280β23 and the estimated interaction log-odds ratio is 140β23 from Equation (4).
iThe estimated genotype log-odds ratio is β32 + 280β33 and the estimated interaction log-odds ratio is 140β33 from Equation (5).
TABLE 4 | Association of the A allele of rs1375713 with metabolic
syndrome depending on the level of moderate to strenuous physical
activity and abdominal obesity status [normal or elevated waist
circumference (WC)].
Physical 1st quartile 3rd quartile
activity level (80 points) (310 points)
OR 95% CI Pa OR 95% CI Pa
TRANSITION MODEL (REFERENCE CATEGORY: NO MetS)
MetS (normal WC) 0.7 (0.4, 1.3) 1.0 2.7 (1.1, 6.5) 0.11
MetS (elevated WC) 1.2 (0.7, 2.0) 1.0 0.8 (0.5, 1.3) 1.0
POLYTOMOUS MODEL (REFERENCE CATEGORY: NO MetS AND
NORMAL WC)
MetS and normal WC 0.6 (0.3,1.3) 1.0 2.6 (1.1, 6.2) 0.16
MetS and elevated WC 0.9 (0.6, 1.3) 1.0 0.8 (0.5, 1.3) 1.0
STANDARD MODEL (REFERENCE CATEGORY: NO MetS)
MetS 0.9 (0.6, 1.2) 0.89 1.0 (0.7, 1.5) 1.0
aP-value after Bonferroni correction was applied as in Table 3.
be seen as a risk factor for MetS in active subjects without
abdominal obesity (A allele OR [95%CI]= 2.7 [1.1, 6.5] at the 3rd
quartile of the physical activity score). By contrast, no association
of rs1375713 to MetS is detected at any level of the physical
activity score when abdominal obesity is ignored. Finally, we
note that when applying the same Bonferroni corrections as in
the simulation study, the interaction test provided a significant
result, but not the genotype effect test (Table 4), even though
the genotype effect test is more powerful than the interaction
test.
Discussion
Our simulation results show that the estimate of the effect of a
genetic variant on disease risk conditioned on an environmental
exposure can be substantially higher when an endophenotype
and an environmental exposure modifying the variant effect are
taken into account in a gene-environment interaction context,
compared to when the endophenotype is ignored. In an analysis
of the interaction of NOX3 SNPs and physical activity in relation
to MetS and abdominal obesity, the association of the A allele
of rs1375713 with MetS at high levels of physical activity was
only detectable in subjects without abdominal obesity, illustrating
the importance of taking into account the abdominal obesity
endophenotype. In that subgroup, our results suggest that
GG homozygotes would achieve the largest MetS prevalence
reduction from physical activity. This gene was selected because
of the association of one SNP with waist circumference in
a genome-wide analysis, but it is another uncorrelated SNP
whose association to MetS in subjects without abdominal obesity
was modified by physical activity. This illustrate that gene-
environment interaction tests are approximately independent of
main effect tests (Dai et al., 2012).
We compared two joint modeling approaches for the disease
and endophenotype: a transition model where the risk of disease
depends on the endophenotype status, which can modify the
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FIGURE 2 | Odds of metabolic syndrome as a function of
moderate to strenuous physical activity score by rs1375713
genotype and abdominal obesity status, at age 40, in the QFS.
X: number of rs1375713 A alleles. Y1 = 1 if abdominal obesity, 0
otherwise. Dashed vertical lines show the first and third quartiles of the
physical activity score.
genetic and environmental effects, and a polytomous model,
where the combination of disease and endophenotype statuses
defines four phenotypic categories. The transition model tended
to produce log-OR estimates closer to the actual log-OR of
the genetic variant in the subgroup where the variant had an
effect, even when the true underlying model of the disease
and endophenotype was a polytomous model, not a transition
model. Considering in addition the simpler interpretation of the
results from the transition model, we are led to favor that model
for joint disease-endophenotype modeling in unascertained
samples. We emphasize that the analysis under a transition
model has two important advantages over a stratified analysis
where the sample is split into subsamples with and without
endophenotype impairment and a logistic regression of disease
status is performed separately in the two subsamples using
Equation (6). First, in a stratified analysis, distinct covariate
coefficients η4 would be estimated in each stratum, leading to
distinct covariate adjustments of the effects of interests, and
difficulties in interpreting differences between strata. Second,
when stratifying a familial sample, dependency between subjects
from the same family in different strata would be ignored in the
variance estimates, resulting in biased inference on differences
between strata.
Environmental exposures such as physical activity levels
are often measured quantitatively. Provided the relationships
of a quantitative exposure with the odds of disease and
endophenotype impairment are approximately linear, treating
the exposure as a continuous variable in regression models
is good modeling practice. We contend that plotting odds
of disease as a function of exposure and estimating an
effect of interest (here a genotype effect) at meaningful levels
of the exposure under a model where the exposure is a
continuous variable is preferable to the common practice in the
epidemiological literature of dichotomizing exposure variables
to estimate effects in exposure strata. In the present study,
we chose to estimate genotype effects at the first and third
quartiles of exposure, which revealed very different genotype
effects.
Endophenotype are also often measured quantitatively. If
the relationship between a quantitative endophenotype and
the risk of disease is smooth, the quantitative endophenotype
could be used in Equation (2) of the transition model, with
Equation (1) being replaced by a linear model. Association with
the disease could then be tested at meaningful levels of the
quantitative endophenotype, and this may provide greater power
than dichotomizing a quantitative endophenotype. We did not
investigate this option in this work because it does not apply to
the relationship between waist circumference and MetS, which
is discontinuous at the threshold for abdominal obesity. At that
threshold, the risk of MetS jumps, since subjects above the
threshold have one more risk factor and are therefore closer to
meeting the definition of MetS.
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We elected to estimate the transition and polytomous models
in unascertained familial samples using GEEs. The effects
estimated by GEEs under logistic models are interpretable as
population-level effects (Fitzmaurice et al., 2011), which are
of interest in a population health perspective. These effects
are attenuated compared to the subject-specific effects specified
in the logistic mixed models used to simulate the data. We
tried a working correlation matrix with relationship-specific
correlations, but noticed no gain in precision when estimating
these correlations compared to setting them to 0 under
the independence working correlation matrix. Since familial
correlations are not the focus of the proposed modeling, we
favor the working independence assumption, as in that case
estimation reduces to fitting logistic and polytomous models
as if the observations were independent. It is well known
that the coefficients of such models (except the intercept) are
estimable under outcome-dependent sampling such as case-
control sampling or ascertainment of family samples based on
phenotype. An alternative to GEEs consists in estimating logistic
and polytomous mixed models by maximum likelihood or
Bayesian a posteriori distribution using a variety of numerical or
Monte Carlo approximations to the likelihood function (Hartzel
et al., 2001; Fitzmaurice et al., 2011). Specification of a familial
correlation structure based on the kinship matrix for the random
effects (derived from a polygenic background model for the trait
liabilities) creates numerical problems, which are not fully solved
(Wang et al., 2015). Estimation of polytomous models with
random effects correlated between logistic functions is already
difficult without kinship structure for the familial correlation
(Hartzel et al., 2001). Taking ascertainment into account in the
likelihood adds further numerical problems (Papachristou et al.,
2011). These limitations led us to avoid logistic and polytomous
mixed models. If one is interested in risk differences under a
transition model, such effects can be estimated under a linear
mixed model (Zhou and Stephens, 2012), but constraints may
be required to keep predicted probabilities between 0 and 1.
We focused instead on ORs, as these are more commonly
used association measures with dichotomous traits. Another
alternative is within-family conditional maximum likelihood
estimation, with conditioning on children phenotypes and
parental genotypes (Cordell et al., 2004; Dudbridge, 2008). We
did not consider this alternative because the conditioning on
phenotype prevents the specification of transition models, only
polytomous models could have been estimated.
In addition to providing effect estimates, Wald hypothesis
tests can be conducted using the empirical variance estimates.
The power of these tests was compared to the power of a
within-family score test derived from the conditional likelihood
under polytomous models (Bureau et al., 2014). Wald tests were
noticeably more powerful than within-family score tests when
data were generated under transition models, but the Wald test
power advantage was reduced when data were generated under
polytomous models, and the within-family score test was even
more powerful than the Wald test to detect interaction effects.
For marginal effects, previous studies had observed lower power
of within-family score tests than the population-level approach
on case-control samples for prevalent traits (Laird and Lange,
2006).
Our results also revealed that a greater effect size does not
always equate to a greater power. With data simulated under
a polytomous model, the power to detect the genotype and
interaction effects were similar or larger in analyses performed
with a disease-only model ignoring the endophenotype than
under transition or polytomousmodels. Estimating largermodels
comes with the price of lower precision of the estimates. We
also noticed that Type I error of Wald tests can be inflated when
modeling a continuous exposure with a subgroup of limited size,
such as the disease cases in the stratum without endophenotype
impairment in our simulations, whose prevalence was based on
MetS cases without abdominal obesity in the QFS (Table 1).
The QFS has several advantages for a study of the interaction
between genes and physical activity in relation toMetS, including
a detailed assessment of physical activity levels, extensive
metabolic traits measurements, and absence of population
stratification confounding in the Quebec City population of
French-Canadian ancestry. In spite of this, the size of the QFS
is limited and estimates lack precision for stratum-specific effects
involving third order interaction terms in the transition models,
or four phenotypic categories in the polytomous models. The
current study was also limited to three SNPs in the NOX3
gene. Replication of the findings reported herein will be needed
before they can be used to promote lifestyle modifications in the
subgroup of subject with MetS without abdominal obesity.
In summary, to identify circumstances under which genetic
variants are strongly associated to a disease, we recommend
estimating distinct genotype effects in subjects with and without
impairment on a key endophenotype, at representative levels of
environmental exposures influencing the trait of interest, under
a joint model of the disease and the endophenotype, preferably
the transition model. This study suggests that such strategy can
be successful when both the environmental exposure and the
endophenotype modify the genetic effect. Implementation
of such modeling requires extensive phenotyping and
environmental exposure characterization, typically available
only on moderate size samples. In such setting, the proposed
strategy should be focused on the most promising candidate
genes, to limit themultiple testing penalty. Consistent phenotypic
and environmental measurements across studies are required to
envision implementing this strategy on a genome-wide scale in
very large samples.
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